Strategic reviews, regulatory submissions, board meetings, competitive analyzes, investor meetings, we understand the importance of timely reportings at every stage of your research project.
Find out how ANS Biotech combines short lead times and high quality standards.
ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain
ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain
This year, Neuroscience will be held in-person in Washington, DC, November 12-15.
Each year, SfN offers to scientists from around the world to congregate and discover new ideas, share their research, and experience the best the field has to offer.
We at ANS Biotech are thrilled to announce our participation in the upcoming SfN 2023.
It’s an exciting opportunity for us to connect with industry peers and to share insights in the field of preclinical pharmacology of pain.
We extend a warm invitation for you to join us on this remarkable event in Neuroscience!
ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain
Assays seamlessly orchestrated during a 3 week experimental phase!
📅 From 10 November to 01 December
ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Assays seamlessly orchestrated during a 3 week experimental phase!
📅 From 22 September to 13 October
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain
We are proud to announce that we have obtained a 5-year approval from the French Ministry of Education and Research to use genetically modified organisms of containment class 1.
Gene therapy with adeno-associated virus (AAV) has advanced in the last few years from promising results in animal models to >100 clinical trials.
We have now the possibility to assess the efficacy of your gene therapy in our facilities.
Should you want to test your AAV in our pain models do not hesitate to contact us.